Overview
Public Biotech
Biotech advancing ketamine therapies including FDA-approved KETARx and PharmaPatch microneedle delivery platform. Developing long-acting injectable ketamine for neuropsychiatric indications.
Visit WebsiteToronto, Canada
$15M
Market Cap
2020
Founded
0
Open Roles
Open Positions
No open positions at this time
Clinical Pipeline
No clinical trials on record